purpos
etiolog
communityacquir
pneumonia
cap
hospit
patient
often
ambigu
due
limit
pathogen
detect
lack
microbiolog
diagnosi
impair
precis
treatment
cap
method
specimen
collect
lower
respiratori
tract
cap
patient
virus
measur
singleplex
realtim
pcr
assay
convent
cultur
method
exploit
bacteria
result
among
patient
pure
bacteri
infect
yeast
infect
pure
viral
infect
viralyeast
coinfect
viralbacteri
coinfect
two
abund
bacteria
acinetobact
baumannii
klebsiella
pneumonia
wherea
common
viru
influenza
conclus
noninfluenza
respiratori
microorgan
frequent
cocircul
epidem
peak
influenza
easili
ignor
cap
therapi
patient
bacteri
viral
coinfect
identifi
etiolog
agent
crucial
patient
therapi
communityacquir
pneumonia
cap
common
diseas
signific
caus
morbid
mortal
worldwid
sever
diseas
affect
variou
factor
includ
age
immun
statu
host
singl
mix
infect
etiolog
cap
essenti
respiratori
ill
lead
similar
clinic
present
current
ambigu
etiolog
lack
microbiolog
diagnosi
cap
impair
pathogendirect
antimicrobi
therapi
last
decad
longterm
implic
respiratori
viral
infect
among
suscept
host
increasingli
recogn
although
approxim
million
case
viral
cap
occur
everi
year
incid
viral
pneumonia
still
underestim
hospit
bacteria
remain
first
consider
pulmonari
infect
antibiot
therapi
still
cornerston
major
cap
influenza
viru
infect
ivi
caus
annual
epidem
result
estim
billion
infect
includ
million
sever
case
mortal
case
worldwid
year
ivi
caus
primari
viral
pneumonia
may
progress
potenti
fatal
outcom
difficult
distinguish
caus
cap
induc
flu
respiratori
virus
bacteria
base
sole
clinic
symptom
convent
lab
biomark
viral
andor
bacteri
infect
differ
influenzaposit
compar
influenzaneg
patient
influenza
temporarili
suppress
host
immun
defens
lead
bacteri
complic
secondari
bacteri
pneumonia
frequent
caus
excess
mortal
influenza
epidem
epidemiolog
remain
unclear
hospit
admiss
influenza
epidem
season
show
moder
strong
associ
influenza
bacteri
pneumonia
wherea
interact
modest
nonexist
nonepidem
period
bacteria
includ
streptococcu
pneumonia
hemophilia
influenza
staphylococcu
aureu
often
interact
respiratori
virus
esp
influenza
viru
shape
outcom
respiratori
infect
studi
shown
evid
bacteri
invas
influenzainfect
case
high
rate
coinfect
exist
patient
indic
viral
infect
may
enhanc
suscept
sever
subsequ
bacteri
infect
vitro
studi
shown
influenza
infect
enhanc
suscept
pneumococc
pneumonia
week
interact
influenza
bacteria
limit
pneumococc
pneumonia
hospit
viral
test
among
patient
respiratori
symptom
uncommon
determin
microbiolog
etiolog
sever
hamper
cap
difficulti
obtain
specimen
infect
area
esp
lower
respiratori
tract
sampl
could
easili
contamin
respiratori
condit
pathogen
present
epidemiolog
histori
influenzalik
ill
ili
incid
clinic
present
cap
caus
virus
influenza
influenza
epidem
season
limit
studi
report
surveil
respiratori
microorgan
laboratori
biomark
cap
patient
admit
hospit
januari
august
specif
microbiom
pattern
clinic
signific
antibacterialantivir
treatment
analyz
patient
simultan
collect
sputum
specimen
cap
patient
admit
first
affili
hospit
shantou
univers
medic
colleg
shantou
citi
guangdong
provinc
china
januari
august
pneumonia
diagnos
acut
ill
fever
cough
dyspnea
tachypnea
least
one
new
focal
chest
sign
confirm
find
lung
shadow
chest
radiograph
like
new
without
obviou
caus
patient
cystic
fibrosi
hiv
infect
exclud
studi
sputum
specimen
collect
store
swab
storag
solut
copan
itali
store
nucleic
acid
extract
use
bead
viral
dnarna
extract
kit
tianlong
china
nucleic
acid
extractor
tianlong
china
respiratori
virus
detect
use
onestep
rtpcr
kit
appli
biosystem
usa
use
realtim
pcr
system
appli
biosystem
usa
negativecontrol
depctreat
water
includ
analyt
procedur
fourteen
respiratori
virus
includ
influenza
influenza
b
parainfluenza
virus
respiratori
syncyti
viru
rsv
coronavirus
human
metapneumoviru
mpv
human
rhinoviru
hrv
bocaviru
bov
adenoviru
adv
measur
procedur
follow
manufactur
protocol
sputum
specimen
cultur
accord
china
nation
standard
protocol
detect
respiratori
bacteria
yeast
specimen
inocul
blood
agar
eosin
methylen
blue
agar
chocol
agar
incub
h
coloni
identif
undertaken
use
vitek
compact
full
automat
identif
system
franc
data
analyz
spss
categor
variabl
summar
compar
test
fisher
exact
test
comparison
two
group
made
use
bonferroni
test
level
adjust
method
continu
variabl
normal
distribut
use
mean
standard
deviat
sd
describ
compar
use
multipl
varianc
multipl
sampl
median
interquartil
rang
iqr
use
describ
nonnorm
distribut
continu
variabl
comparison
base
nonparametr
kruskalw
h
test
signific
differ
among
two
group
mannwhitney
u
test
use
signific
differ
two
group
tabl
patient
includ
male
femal
fifteen
case
children
mean
age
yr
case
adult
mean
age
yr
twenti
patient
previous
pulmonaryassoci
diseas
includ
case
copd
case
tuberculosi
case
pulmonari
heart
diseas
case
emphysema
total
patient
least
underli
diseas
includ
high
blood
pressur
diabet
heart
diseas
epilepsi
tumor
hepat
admiss
broadspectrum
antibiot
prescrib
patient
empir
definit
therapi
patient
given
antivir
treatment
patient
given
antivir
plu
antibiot
treatment
frequent
use
antibiot
quinolon
cephalosporin
frequent
use
antivir
agent
oseltamivir
ribavirin
recombin
human
interferon
unfortun
patient
die
adult
male
femal
age
yr
averag
age
yr
singlebacteri
infect
found
patient
singleyeast
infect
found
patient
singlevir
infect
found
patient
coinfect
viru
bacterium
viru
yeast
found
patient
pathogen
could
unidentifi
case
tabl
bacteri
infect
identifi
patient
two
frequent
detect
bacteria
baumannii
k
pneumonia
account
bacteri
infect
addit
case
infect
p
aeruginosa
aureu
respect
case
e
coli
tabl
three
case
one
bacteri
infect
aureu
plu
k
ornithinolytica
baumannii
plu
p
aeruginosa
pneumonia
plu
e
aerogen
respect
viral
infect
identifi
patient
influenza
influenza
b
rsv
common
virus
among
case
follow
mpv
tabl
specif
patient
one
viru
account
virusposit
group
dual
viral
infect
observ
rsv
coinfect
hrv
respect
coinfect
bov
respect
influenza
coinfect
mpv
hrv
respect
patient
coinfect
includ
singl
viru
singl
bacterialyeast
coinfect
case
two
virus
singl
bacterium
yeast
coinfect
case
patient
bacterialyeast
coinfect
noninfluenza
virus
frequent
bacteri
yeast
influenza
coinfect
tabl
fever
cough
short
breath
common
clinic
sign
observ
bacteri
case
viral
case
yeast
case
coinfect
case
respect
bacteri
group
significantli
differ
viral
group
coinfect
group
cough
time
viral
group
yeast
group
cough
also
signific
differ
tabl
patient
pure
noninfluenza
infect
patient
noninfluenza
bacterium
yeast
coinfect
admit
icu
patient
die
noninfluenza
coinfect
bacterium
yeast
group
tabl
patient
pharyng
discomfort
found
pure
influenza
group
bacterium
yeast
coinfect
noninfluenza
virus
common
bacterium
yeast
influenza
coinfect
wbc
count
noninfluenza
group
significantli
higher
influenza
group
highest
wbc
count
observ
noninfluenza
bacterium
yeast
coinfect
group
plt
count
p
also
similar
trend
flu
season
case
baumannii
infect
greater
nonflu
season
case
vs
case
noteworthi
bacteria
h
influenza
b
catarrhali
maltophilia
e
cloaca
k
ornithinolytica
marcescen
haemolyticu
pneumonia
detect
nonflu
season
emerg
influenza
virus
flu
flu
b
common
flu
season
viru
like
mpv
smaller
flu
influenza
season
tabl
pathogendirect
therapi
avoid
unnecessari
antibiot
antivir
use
facilit
time
henc
effect
use
drug
help
prevent
secondari
spread
infect
shorten
hospit
stay
major
impact
patient
manag
diseas
prognosi
accur
rapid
etiolog
diagnosi
crucial
pathogendirect
therapi
date
gold
standard
cap
diagnosi
still
base
radiograph
find
radiolog
find
multilobar
infiltr
pleural
effus
gener
indic
greater
sever
although
etiolog
studi
perform
current
microbi
diagnost
test
frequent
allow
clinician
rule
bacteri
infect
certainti
obtain
qualifi
sampl
may
challeng
specimen
easili
contamin
bacteria
locat
upper
airway
increas
detect
rate
pathogen
esp
infect
occur
lower
respiratori
tract
alveolar
lavag
fluid
may
better
reflect
infecti
statu
sputum
howev
alveolar
lavag
fluid
requir
semiinvas
surgeri
certainli
routin
nonintub
patient
esp
children
condit
take
sputum
sampl
practic
therefor
relev
cap
guidelin
recommend
sputum
examin
patient
moder
sever
cap
studi
high
microbi
yield
achiev
real
time
pcr
assay
plu
convent
diagnost
method
bacteri
cultur
singleplex
real
time
tabl
clinic
symptom
bacterium
group
viru
group
yeast
group
coinfect
group
pcr
assay
exploit
detect
respiratori
virus
could
improv
diagnost
efficaci
particularli
diagnos
respiratori
viral
infect
etiolog
diagnosi
cap
patient
reach
still
cap
patient
without
clearli
microorgan
diagnos
patient
comorbid
use
antibiot
prior
sampl
may
obscur
potenti
bacteri
detect
previou
studi
reveal
etiolog
remain
unknown
approxim
onehalf
case
indic
establish
precis
pathogen
diagnosi
cap
patient
challeng
better
diagnost
method
warrant
distinguish
viral
influ
group
compar
noninflu
group
influ
group
compar
noninflu
bacteriumyeast
group
noninflu
group
compar
influ
bacterium
yeast
group
influ
bacteriumyeast
group
compar
noninflu
bacterium
yeast
group
number
bacteri
infect
viral
infect
influenza
season
nonflu
season
bacteri
cap
clarifi
viral
infect
caus
cap
mere
predispos
patient
bacteri
coinfect
differ
epidemiolog
make
knowledg
local
etiolog
crucial
appropri
choic
empir
antimicrobi
treatment
even
sever
influenza
outbreak
studi
respiratori
viral
infect
influenza
infect
vs
pathogen
caus
cap
bacteria
occupi
major
pathogen
common
bacterium
baumannii
result
keep
previou
studi
frequent
identifi
pathogen
burkholderia
pseudomallei
pneumonia
k
pneumonia
h
influenza
respect
although
baumannii
import
pathogen
nosocomi
infect
often
isol
infecti
patient
first
admit
hospit
indic
baumannii
certain
popular
area
communityacquir
case
baumannii
pneumonia
tropic
subtrop
countri
asiapacif
region
thailand
sever
cap
caus
baumannii
mortal
time
higher
hospitalacquir
baumannii
pneumonia
anoth
aspect
patient
underli
diseas
could
exclud
possibl
patient
bacteri
infect
last
hospit
admiss
pathogen
remain
respiratori
tract
caus
clinic
symptom
bodi
immun
reduc
outbreak
baumannii
infect
also
associ
multidrug
resist
carbapenem
consid
major
factor
resist
multidrugresist
baumannii
infect
moreov
mortal
carbapenemresist
baumannii
pneumonia
patient
higher
carbapenemsensit
baumannii
pneumonia
patient
pneumonia
h
influenza
copathogen
often
seem
part
mix
infect
viru
bacterium
adult
cap
repres
common
combin
respiratori
virus
incid
mix
infect
signific
among
patient
admit
hospit
cap
studi
cap
patient
singl
viru
coinfect
viru
bacterium
viru
yeast
found
cap
patient
incid
coinfect
agreement
previou
studi
common
bacterium
codetect
viru
k
pneumonia
well
yeast
studi
indic
geograph
variat
exist
preval
bacterium
yeast
strain
express
factor
enabl
effici
diseas
potenti
viral
epidem
consid
one
explan
region
differ
sever
divers
etiolog
reveal
understand
local
etiolog
cap
essenti
inform
clinic
manag
decis
respiratori
virus
usual
follow
season
pattern
activ
epidem
influenza
note
studi
area
activ
throughout
studi
period
high
detect
rate
influenza
ainfluenza
b
januari
may
influenza
epidem
season
high
percentag
sampl
cap
patient
contain
least
one
viru
dual
infect
common
respiratori
viru
influenza
account
viral
cap
studi
reveal
respiratori
virus
cocircul
even
highest
epidem
peak
influenza
show
season
distribut
bacteri
fungal
infect
secondari
influenza
viral
infect
common
though
could
exclud
increas
coinfect
cap
due
secondari
viral
infect
clinic
sign
symptom
overlap
influenza
noninfluenza
virus
pathogendirect
therapi
difficult
base
clinic
symptom
studi
shown
delay
antivir
treatment
associ
high
risk
progress
sever
diseas
requir
icu
admiss
prolong
hospit
stay
even
caus
death
microbiom
character
divers
close
link
host
statu
host
immun
respons
may
play
determin
role
infecti
exacerb
cap
intrins
complex
hostmicrobiom
relationship
current
limit
clinic
indic
microbiom
analysi
diabet
high
blood
pressur
common
underli
diseas
known
associ
increas
risk
complic
death
among
critic
ill
patient
detect
respiratori
secret
pcr
method
provid
rapid
definit
diagnosi
ili
hospit
adult
unfortun
routin
test
clinic
lab
appropri
empir
therapi
like
suboptim
without
narrow
diagnost
possibl
like
possibl
pend
definit
pathogen
identif
effect
target
therapi
cap
requir
understand
heterogen
etiolog
individu
host
respons
infect
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
studi
approv
ethic
committe
shantou
univers
medic
colleg
inform
consent
obtain
patient
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
